Mason C D, Rand T G, Oulton M, MacDonald J, Anthes M
Department of Biology, Saint Mary's University, Halifax, Nova Scotia, Canada.
Toxicol Appl Pharmacol. 2001 Apr 1;172(1):21-8. doi: 10.1006/taap.2001.9127.
We have shown recently that alveolar type II cells are sensitive to exposure to Stachybotrys chartarum spores, both in vitro and in an in vivo juvenile mouse model. In mice, this sensitivity is manifest in part as a significant increase in the newly secreted, biologically active, heavy aggregate form of alveolar surfactant (H) and the accumulation of the lighter, "metabolically used", biologically inactive alveolar surfactant forms (L(vivo)) in the interalveolar space. Conversion of the heavy, surface-active alveolar surfactant to the light metabolically used, nonsurface active forms is believed to involve the activity of an enzyme, namely convertase, which is thought to be derived from lamellar bodies (LB) in alveolar type II cells. The purpose of this study was to evaluate the effects of S. chartarum spores on mouse H and LB convertase activity by measuring their rates of conversion to L(vivo) using the in vitro surface area cycling technique. It was determined whether there were concurrent changes in the protein and phospholipid concentrations of the raw bronchoalveolar lavage fluid (RL) and LB fractions that could be correlated with changes in convertase activity. Conversions of H to L(vivo) in untreated control mice and saline-, isosatratoxin F-, and Cladosporium cladosporioides-exposed mice were not significantly different (p > 0.05). However, conversion from H to L(vivo) in the mice exposed to S. chartarum spores was significantly higher than all other treatment groups (p < 0.001). LB to L(vivo) conversions in untreated and saline-exposed mice were not significantly different, although they were significantly higher than the H to L(vivo) conversions in these two animal treatment groups (p < 0.005), which supports the position that LB is a source of convertase activity in animals. LB to L(vivo) conversion from C. cladosporioides-, isosatrotoxin F-, and S. chartarum-exposed mice were all significantly depressed (p < 0.003) compared to the LB to L(vivo) conversion values obtained from untreated and saline-exposed mice. Protein concentrations in RL, H, L(vivo), and LB from mice exposed to S. chartarum spores were significantly elevated compared to those from the other treatment groups (p < 0.001). Protein concentration in H isolated from C. cladosporioides-exposed mice was also significantly elevated above untreated and saline control animal levels. Phospholipid concentrations in H isolated from S. chartarum-exposed mice were significantly elevated compared to those from other treatment groups, while LB phospholipid concentrations were significantly increased compared to saline and untreated control animal groups. These results show that S. chartarum spores significantly alter convertase activity in both the H and LB surfactant fractions in juvenile mice and that these changes can be related to changes in protein and phospholipid concentrations in alveolar lavage fractions. As surfactant promotes lung stability by reducing the surface tension of the air-alveolar interface, these results further support our position that inhalation exposure to S. chartarum spores in exposed individuals may lead to altered surfactant metabolism, and possibly to lung dysfunction through diminished alveolar surfactant surface tension attributes, and lung stability.
我们最近发现,在体外以及幼年小鼠体内模型中,II型肺泡细胞对暴露于展青霉孢子敏感。在小鼠中,这种敏感性部分表现为肺泡表面活性物质新分泌的、具有生物活性的重聚集体形式(H)显著增加,以及较轻的、“代谢消耗的”、无生物活性的肺泡表面活性物质形式(L(体内))在肺泡间隙中积累。重的、具有表面活性的肺泡表面活性物质向轻的、代谢消耗的、无表面活性形式的转化被认为涉及一种酶即转化酶的活性,该酶被认为源自II型肺泡细胞中的板层小体(LB)。本研究的目的是通过使用体外表面积循环技术测量其向L(体内)的转化率,来评估展青霉孢子对小鼠H和LB转化酶活性的影响。确定了原始支气管肺泡灌洗液(RL)和LB组分的蛋白质和磷脂浓度是否存在同时发生的变化,这些变化可能与转化酶活性的变化相关。未处理的对照小鼠以及暴露于盐水、异孢镰刀菌素F和枝孢霉菌的小鼠中,H向L(体内)的转化没有显著差异(p>0.05)。然而,暴露于展青霉孢子的小鼠中从H到L(体内)的转化显著高于所有其他处理组(p<0.001)。未处理和暴露于盐水的小鼠中LB向L(体内)的转化没有显著差异,尽管它们显著高于这两个动物处理组中H向L(体内)的转化(p<0.005),这支持了LB是动物体内转化酶活性来源的观点。与从未处理和暴露于盐水的小鼠获得的LB向L(体内)转化值相比,暴露于枝孢霉菌、异孢镰刀菌素F和展青霉孢子的小鼠的LB向L(体内)转化均显著降低(p<0.003)。与其他处理组相比,暴露于展青霉孢子的小鼠的RL、H、L(体内)和LB中的蛋白质浓度显著升高(p<0.001)。从暴露于枝孢霉菌的小鼠中分离出的H中的蛋白质浓度也显著高于未处理和盐水对照动物水平。与其他处理组相比,从暴露于展青霉孢子的小鼠中分离出的H中的磷脂浓度显著升高,而LB磷脂浓度与盐水和未处理对照动物组相比显著增加。这些结果表明,展青霉孢子显著改变幼年小鼠H和LB表面活性物质组分中的转化酶活性,并且这些变化可能与肺泡灌洗组分中蛋白质和磷脂浓度的变化有关。由于表面活性物质通过降低气-肺泡界面的表面张力来促进肺稳定性,这些结果进一步支持了我们的观点,即暴露个体吸入展青霉孢子可能导致表面活性物质代谢改变,并可能通过降低肺泡表面活性物质的表面张力属性和肺稳定性而导致肺功能障碍。